MD MEDNAX Inc.

Statement from Southeast Anesthesiology Consultants and Mednax Services, Inc.

Southeast Anesthesiology Consultants (“Southeast”), an affiliate of MEDNAX, Inc. (NYSE:MD) today filed a motion with the North Carolina Business Court seeking a temporary restraining order and preliminary injunction against Atrium Health and Dr. Thomas Wherry’s Scope Anesthesia.

The motion seeking a temporary restraining order is necessary given that for some time, Dr. Wherry and Atrium have been attempting to recruit physicians from Southeast, in violation of the contract Southeast has with Atrium as well as contrary to statements both Atrium and Dr. Wherry have made to the press. The motion requests the judge to order the defendants to cease such solicitation immediately.

Additionally, the motion seeking a preliminary injunction details how Atrium and Dr. Wherry improperly obtained highly proprietary information related to staffing the anesthesia treatment locations where Southeast currently provides services.

Despite Atrium’s continued attempts to impugn our practice and our intent, Southeast and MEDNAX are proven assets to Charlotte and the surrounding region. Our 88 physicians stand ready, willing and able to continue serving patients as we have done faithfully and tirelessly since 1981.

Atrium Health and Southeast have built one of the highest quality anesthesia programs in the country that took years to develop and refine. We believe Atrium is destroying a highly successful program as a means to improve its bottom line, with little consideration for the potential damage it can do to the communities that it serves as the region’s public hospital system.

EN
12/05/2018

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on MEDNAX Inc.

Pediatrix Medical Group Inc.: 1 director

A director at Pediatrix Medical Group Inc. sold 23,000 shares at 22.410USD and the significance rating of the trade was 58/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two ...

Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vital Signs: Actionable charts

In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.

Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vital Signs: Actionable charts

In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.

Mednax, Inc.: Covenant Quality Post-Sale Snapshot: $400m 5.375% Senior...

Mednax. Inc.’s covenant package provides lower-tier HY-Lite protection, reflecting a covenant quality score of 5.00.

ResearchPool Subscriptions

Get the most out of your insights

Get in touch